Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Cash from Investing Activities (2011 - 2026)

Palatin Technologies' (PTN) quarterly Cash from Investing Activities came in at -$38483.0 in Q1 2026, down 106.11% on a QoQ basis from $630000.0 in Q2 2025.

Palatin Technologies (PTN) Cash from Investing Activities (2011 - 2026) Analysis & Trends

Palatin Technologies (PTN) has 14 years of Cash from Investing Activities data on file, last reported at -$38483.0 in Q1 2026.

  • Quarterly Cash from Investing Activities changed N/A year-over-year to -$38483.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 23.9% YoY) and the FY2025 annual result came in at $3.1 million, down 74.86% from the prior year.
  • Cash from Investing Activities slipped to -$38483.0 in Q1 2026, from $630000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $9.5 million in Q4 2023 to a low of -$3.0 million in Q2 2023.
  • A 5-year average of $1.0 million and a median of -$37799.5 in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 3711500.0% — and 2025, when it surged 12928.34%.
  • Tracing PTN's Cash from Investing Activities over 5 years: stood at -$123428.0 in 2022, then jumped by 7766.32% to $9.5 million in 2023, then sank by 73.58% to $2.5 million in 2024, then slumped by 74.8% to $630000.0 in 2025, then tumbled by 106.11% to -$38483.0 in 2026.
  • The last three Cash from Investing Activities figures came in at -$38483.0 (Q1 2026), $630000.0 (Q2 2025), and $2.5 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Palatin Technologies 40.37 Mn 40.37 Mn - -38,483.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -38,483.00
Mar 31, 2026 -38,483.00
Jun 30, 2025 630,000.00
Jun 30, 2025 630,000.00
Dec 31, 2024 2.50 Mn
Dec 31, 2024 2.50 Mn
Jun 30, 2024 -4,911.00
Jun 30, 2024 -4,911.00
Dec 31, 2023 9.46 Mn
Dec 31, 2023 9.46 Mn
Sep 30, 2023 2.99 Mn
Sep 30, 2023 2.99 Mn
Jun 30, 2023 -3.05 Mn
Jun 30, 2023 -3.05 Mn
Mar 31, 2023 -116,875.00
Mar 31, 2023 -116,875.00
Dec 31, 2022 -123,428.00
Dec 31, 2022 -123,428.00
Sep 30, 2022 -141,228.00
Sep 30, 2022 -141,228.00